The Recombinant Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiac Fibroblasts Injury Against an in Vitro Ischemia/Reperfusion Injury

Journal of Applied Pharmaceutical Science - India
doi 10.7324/japs.2018.8620
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Journal of Applied Pharmaceutical Science


Related search